immunotherapy
Oncology/ Views & Analysis/ Views and analysis
Using bispecific antibodies to advance cancer immunotherapy
mike.hammerton@pharmaphorum.com
cancer, immunotherapy
0 Comment
Allergy specialist Stallergenes taps Aptar for digital delivery
Phil Taylor
allergy, Aptar, digital, digital health, immunotherapy, non-adherence, Stallergenes Greer
0 Comment
R&D/ Views & Analysis/ Views and analysis
Targeting COVID-19 and cancer with immunotherapy advancements
mike.hammerton@pharmaphorum.com
: Anna Biosciences, cancer, COVID-19, immuno-oncology, immunotherapy, Oncology
0 Comment
Oncology/ Slider in video/ Video/ Views & Analysis/ Views and analysis
Health Innovators – Jo Brewer, Adaptimmune
Paul Tunnah
Adaptimmune, cell therapy, health innovators, immunotherapy, Innovation
0 Comment
Deep Dive/ Digital/ Market Access/ Oncology/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis
Deep Dive: Oncology 2021
George Underwood
asco, ASCO 2021, COVID-19, Deep Dive, digital health, immuno-oncology, immunotherapy, Oncology
0 Comment
Oncology/ Views & Analysis/ Views and analysis
Changing focus to cachexia may be key to improved cancer outcomes
Catherine Longworth
cachexia, cancer, immunotherapy, Oncology
0 Comment
Oncology/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
The next generation of immunotherapy? Innate Pharma targets NK cells
Catherine Longworth
immunotherapy, Innate Pharma, Oncology, Sezary Syndrome
0 Comment
Triple Negative Breast Cancer Drug Development Digital Summit
jenna.warren@hansonwade.com
adc, immunotherapy, Oncology, PARP inhibitor, TNBC
0 Comment
Fast-track the Discovery & Development of TNBC